Search Results - "Zeevat, Florian"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach

    Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach by Zeevat, Florian, Simons, Joost J. M., Westra, Tjalke A., Wilschut, Jan C., van Sorge, Nina M., Boersma, Cornelis, Postma, Maarten J.

    Published in Infectious diseases and therapy (01-03-2024)
    “…Introduction Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is a rapidly progressing, rare disease that often presents as meningitis or…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost

    Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost by Zeevat, Florian, Dvortsin, Evgeni, Wondimu, Abrham, Wilschut, Jan C, Boersma, Cornelis, Postma, Maarten J

    Published in Vaccines (Basel) (10-02-2021)
    “…In this study, we estimated the benefits of rotavirus vaccination for infants had the rotavirus vaccine been introduced in the Netherlands as of its market…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Reply to Anglemyer et al

    Reply to Anglemyer et al by Zeevat, Florian, Boersma, Cornelis, Postma, Maarten

    Published in The Journal of infectious diseases (04-05-2022)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations

    Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations by van der Pol, Simon, Zeevat, Florian, Postma, Maarten J., Boersma, Cornelis

    Published in Vaccine (31-05-2024)
    “…•The cost-effectiveness of implementing high-dose influenza vaccination (HD-QIV) was assessed.•A health-economic model was developed, including morbidity,…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Reducing Hospital Capacity Needs for Seasonal Respiratory Infections: The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults

    Reducing Hospital Capacity Needs for Seasonal Respiratory Infections: The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults by Zeevat, Florian, Wilschut, Jan C., Boersma, Cornelis, Postma, Maarten J.

    Published in Value in health (01-04-2023)
    “…Influenza is responsible for considerable health and economic burden every year. Especially older adults are vulnerable for influenza infection and its…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program

    Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program by Zeevat, Florian, Crépey, Pascal, Dolk, F. Christiaan K., Postma, Arjan J., Breeveld-Dwarkasing, Vidya N.A., Postma, Maarten J.

    Published in Value in health (01-01-2021)
    “…As of 2019, quadrivalent influenza vaccine (QIV) has replaced trivalent influenza vaccine (TIV) in the national immunization program in The Netherlands. Target…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: